UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ABBV — AbbVie Inc.
CIK 861177
NEW YORK, NY
Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,080,007,683
+$126,931,868 QoQ
Shares Held
14,161,606
+9.6% QoQ
Ownership
0.802%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 53.953513464503956.ToString("F0")%
Shared 0.ToString("F0")%
None 46.046486535496044.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $23,080,171,805 across 16 Drug Manufacturers - General names. ABBV ranks #3 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,072,021 | $6,504,632,749 | |
| 2 | JNJ |
Johnson & Johnson
|
19,628,113 | $4,797,895,938 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
14,161,606 | $3,080,007,683 | |
| 4 | MRK |
Merck & Co., Inc.
|
20,414,819 | $2,455,698,571 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
13,199,103 | $1,839,558,979 | |
| 6 | AMGN |
Amgen Inc
|
4,784,982 | $1,683,595,911 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
22,719,320 | $1,377,926,752 | |
| 8 | PFE |
Pfizer Inc
|
34,522,932 | $969,403,925 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,080,007,683 | 14,161,606 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,953,075,815 | 12,924,311 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,913,032,751 | 12,581,121 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,710,534,048 | 14,602,597 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,675,958,846 | 12,771,854 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $2,142,832,050 | 12,058,706 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,009,541,859 | 10,175,926 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,645,386,723 | 9,592,973 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,594,278,392 | 8,754,961 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,370,552,504 | 8,843,986 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,402,095,170 | 9,406,247 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,345,059,298 | 9,983,369 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,591,049,512 | 9,983,369 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,740,488,462 | 10,769,683 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,453,585,286 | 10,830,678 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,686,503,875 | 11,011,386 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,632,981,846 | 10,073,295 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,508,026,430 | 11,137,566 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,319,675,749 | 12,233,946 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,246,612,328 | 11,067,226 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,244,136,507 | 11,496,364 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,225,638,592 | 11,438,531 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $803,651,995 | 9,175,157 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $858,987,812 | 8,749,112 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $463,462,164 | 6,082,979 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||